We dodged a bullet… for now! I’m pleased to report that the House just approved the FY12 DoD Appropriations Bill by a vote of 331-83. No amendments were offered to reduce or eliminate CDMRP (the Department of Defense Medical Research Program) funding. At this time we have managed to maintain the funding for the Prostate [...]
Yesterday there was an amendment passed on the House floor to restore the Prostate Cancer Research Program's 2012 funding to $80 million. The Department of Defense (DoD) Appropriations Bill (H.R. 2219) originally was slated to allocate only $64 million to the Prostate Cancer Research Program (PCRP), a 20% reduction from last year’s funding. Restoring these [...]
Things are looking up for our European readers. It must be frustrating for people outside of the United States to read this blog and learn about the many advances we now have in the US which are not available to them. The good news is that Sanofi has just launched Jevtana (cabazitaxel) in the UK [...]
My personal belief is what does it matter since all of our goals really should be finding ways to live our lives to the fullest, gain all possible life extensions while also maintaining a decent quality of life. There are things that are just out of our personal control, those we just need to accept. [...]
Yesterday Dendreon, the producers of Provenge, received word from the FDA that their plant in California had been approved to manufacture Provenge. This afternoon they received a positive response from the Centers for Medicare and Medicaid Services (CMS) that a final National Coverage Decision (NCD) for Provenge has been issued requiring Medicare contractors to cover [...]